ERBB2 and hepatocellular carcinoma: Heinze et al. also identified an association between HER2 expression and poor prognosis, but this was not verified in other studies [28,32]. HER2 overexpression in HCC and its clinical significance need to be clarified as it can be a new targeted option in HCC.